Health Care Select Sector SPDR Fund (XLV)
| Assets | $30.46B |
| NAV | $131.18 |
| Expense Ratio | 0.12% |
| PE Ratio | 17.60 |
| Shares Out | 232.22M |
| Dividend (ttm) | $1.81 |
| Dividend Yield | 1.38% |
| Ex-Dividend Date | Sep 20, 2021 |
| 1-Year Return | - |
| Volume | 8,009,739 |
| Open | 131.02 |
| Previous Close | 131.14 |
| Day's Range | 130.82 - 131.72 |
| 52-Week Low | 98.82 |
| 52-Week High | 136.56 |
| Beta | 0.77 |
| Holdings | 66 |
| Inception Date | Dec 16, 1998 |
About XLV
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Top 10 Holdings
50.03% of assets| Name | Symbol | Weight |
|---|---|---|
| Johnson & Johnson | JNJ | 8.61% |
| UnitedHealth | UNH | 8.35% |
| Pfizer | PFE | 4.81% |
| Thermo Fisher Scientific | TMO | 4.79% |
| Abbott Laboratories | ABT | 4.44% |
| Merck | MRK | 4.11% |
| Danaher | DHR | 3.95% |
| AbbVie | ABBV | 3.85% |
| Eli Lilly | LLY | 3.83% |
| Medtronic | MDT | 3.27% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 20, 2021 | $0.467 | Sep 23, 2021 |
| Jun 21, 2021 | $0.48083 | Jun 24, 2021 |
| Mar 22, 2021 | $0.39747 | Mar 25, 2021 |
| Dec 21, 2020 | $0.46434 | Dec 24, 2020 |
| Sep 21, 2020 | $0.41836 | Sep 24, 2020 |
| Jun 22, 2020 | $0.42481 | Jun 25, 2020 |
News
Buy 5 High-Beta ETFs That Still Offer Value
The S&P 500 Index is currently trading at a forward P/E of 20.3X, which is higher than five-year and 10-year average. With holiday season approaching, investors can try these high-beta ETFs with low P/E...
3 Stocks to Buy Where Wall Street Is Focused on Fear
While investor confidence is rattled, it is easier to find good stocks to buy on dips. The economy doesn't warrant a market crash yet.
A bear and a bull debate the move in health care after Merck's Covid pill breakthrough
Health-care stocks ended last week divided. Market analysts are divided, too.
ETF Spotlight: Healthcare ETF XLV down 5% since September
In Wednesday's ETF Spotlight, CNBC's Morgan Brennan takes a look at the healthcare sector and a recent upgrade on Eli Lilly.
5 ETFs to Combat Stimulus Tapering Concerns, Virus Woes
Here we discuss some ETFs that seem like good additions to the portfolio given that the present market scenario is largely dominated by Fed's stimulus tapering concerns.
7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In
Covid-19 showed us how rapid advances in medicine and technology could create significant growth opportunities for healthcare stocks. The post 7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In ...
Cigna announces accelerated stock repurchase agreement worth $2 billion
CNBC's Carl Quintanilla reports on the rise of a healthcare ETF and Cigna's latest announcement
5 Hot Equity ETFs of Last Week Amid Volatility
ETFs overall gathered about $18 billion capital last week (Aug 16-19), bringing in inflows of $563.2 billion year to date.
Here's what you should do now with your mega-cap Big Tech stocks
Crossmark Chief Strategist Victoria Fernandez tells Wilfred Frost on Closing Bell that it's a good idea to trim back on big cap tech and take some profits while the stocks are high. She is joined in thi...
5 ETFs to Bet on Fed's Stimulus Tapering Concerns, Weak Data
Here we discuss some ETFs that seem like a good addition to the portfolio considering the present market scenario largely dominated by Fed's tapering concerns.
Healthcare ETF (XLV) Hits a New 52-Week High
The Health Care Select Sector SPDR Fund (XLV) hits a new 52-week high. Are more gains in store?
Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win
Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.
If a serious sell-off strikes the market, this 'underrated' group should help investors avoid big losses
"We remain optimistic that health care can do well especially in periods of angst," Ally Invest's Lindsey Bell says.
Stocks at Record: Buy 5 Top Cheap ETFs With High Potential
Wall Street has rallied hard this year on vaccine distribution, a prolonged period of easy money policy, fiscal stimulus and stronger-than-expected earnings.
Health care and financial stocks are up
Pete Najarian, co-founder of MarketRebellion.com, and Joe Terranova, senior managing director for Virtus Investment Partners, join the Halftime Report to discuss why they're buying Bank of America and o...
Cigna's 2021 Earnings Hit by the Pandemic
The healthcare sector and related exchange traded funds look ill after Cigna (NYSE: CI) warned of the negative full-year impact of the coronavirus pandemic. On Thursday, the iShares U.S. Healthcare Prov...
5 Top-Ranked ETF Winners of July With More Upside Potential
The month of July was marked with huge volatility for Wall Street.
5 Top-Ranked ETFs Looking Good After a Decent July
Here we discuss some top-ranked ETFs that seem like a good addition to the portfolio considering the present market scenario largely dominated by delta variant concerns.
The Healthcare Sector Is Still an Appealing Bet
The healthcare sector, the second-largest sector weight in the S&P 500 behind technology, is considered a defensive group, making it particularly relevant for retirees and investors nearing retirement. ...
Monday Was the Biggest Day of Selling Since Pandemic
Monday saw huge selling in stocks and ETFs, but those hoping to play a near-term bounce could look to small caps and health care.